When is the next results date for Evoq Remedies?
2025-10-10 23:16:10Evoq Remedies will declare its results on 10 October 2025....
Read MoreHow has been the historical performance of Evoq Remedies?
2025-10-10 22:37:07Answer: The historical performance of Evoq Remedies shows significant fluctuations in its financial metrics over the years. Breakdown: Evoq Remedies reported net sales of 11.76 Cr in March 2025, a notable increase from 4.05 Cr in March 2024, but a decline from 20.39 Cr in March 2023. The total operating income mirrored this trend, reaching 11.76 Cr in March 2025, up from 4.05 Cr in the previous year, yet down from 20.39 Cr in March 2023. The total expenditure, excluding depreciation, was 13.99 Cr in March 2025, rising from 5.69 Cr in March 2024, while the operating profit (PBDIT) was slightly positive at 0.18 Cr, down from 0.62 Cr in March 2024 and 2.28 Cr in March 2023. The profit before tax decreased to 0.13 Cr in March 2025 from 0.61 Cr in March 2024, and the profit after tax also fell to 0.09 Cr from 0.45 Cr in the previous year. The company's total assets increased to 50.01 Cr in March 2025 from 36.86...
Read MoreHow has been the historical performance of Evoq Remedies?
2025-10-09 22:39:29Answer: The historical performance of Evoq Remedies shows fluctuations in key financial metrics over the years, with notable changes in net sales, operating profit, and profit after tax. Breakdown: Evoq Remedies experienced a significant increase in net sales from Mar'24 to Mar'25, rising from 4.05 Cr to 11.76 Cr, although this was a decrease from the previous year, Mar'23, where sales peaked at 20.39 Cr. Total operating income followed a similar trend, reflecting the same values as net sales. The company's total expenditure, however, increased sharply to 13.99 Cr in Mar'25 from 5.69 Cr in Mar'24, leading to an operating profit (PBDIT) of -2.23 Cr in Mar'25, which indicates a loss compared to the profit of 0.62 Cr in Mar'24. Profit before tax also decreased to 0.13 Cr in Mar'25 from 0.61 Cr in Mar'24, resulting in a profit after tax of 0.09 Cr in Mar'25, down from 0.45 Cr in Mar'24. On the balance sheet, t...
Read MoreWhen is the next results date for Evoq Remedies?
2025-10-06 23:15:44Evoq Remedies will declare its results on 09 October 2025....
Read MoreWhy is Evoq Remedies falling/rising?
2025-10-02 00:03:01As of 01-October, Evoq Remedies Ltd is experiencing a decline in its stock price, currently at 3.90, which reflects a decrease of 0.05 or 1.27%. The stock has been underperforming, having lost 14.85% over the last four days, and it has underperformed its sector by 2.63% today. In terms of longer-term performance, the stock has seen a significant drop of 50% year-to-date and a staggering 75.62% decline over the past three years. While the stock is currently trading above its 50-day moving average, it remains below the 5-day, 20-day, 100-day, and 200-day moving averages, indicating a bearish trend. The rising investor participation, with a 32.35% increase in delivery volume, suggests some interest, but the overall sentiment remains negative. In the broader market context, the Sensex has only declined by 0.90% over the past week, contrasting sharply with Evoq Remedies' 12.56% drop in the same period. This ind...
Read MoreWhy is Evoq Remedies falling/rising?
2025-09-29 23:39:24As of 29-Sep, Evoq Remedies Ltd is experiencing a decline in its stock price, currently at 4.15, which reflects a decrease of 0.21 or 4.82%. The stock has underperformed its sector by 4.96% today and has been on a consecutive downward trend for the last two days, resulting in a total drop of 9.39% during this period. Over the past week, the stock has decreased by 2.81%, while its one-month performance shows a significant increase of 35.18%. However, year-to-date, the stock has fallen by 46.79%, indicating a longer-term struggle. Additionally, the delivery volume has decreased by 59.68% against the five-day average, suggesting a decline in investor participation, which may contribute to the stock's recent price movement. In the broader market context, the Sensex has also faced challenges, with a decline of 2.18% over the past week. While Evoq Remedies has outperformed the benchmark in the one-month period, ...
Read MoreWhy is Evoq Remedies falling/rising?
2025-09-24 23:33:10As of 24-Sep, Evoq Remedies Ltd is experiencing a price increase, with its current price at 4.55, reflecting a change of 0.38 or 9.11% upward. The stock has shown strong performance in the short term, with a 1-week return of +27.09% and a 1-month return of +32.65%, significantly outperforming the Sensex, which has seen a decline of -1.18% over the same week and a modest increase of +0.50% over the month. However, despite this recent upward trend, the stock's year-to-date performance remains concerning, with a decline of -41.67%. Today's price summary indicates that the stock has outperformed its sector by 9.56%, but there is a noted decrease in investor participation, with delivery volume falling by -16.67% compared to the 5-day average. Additionally, while the stock is trading above its 5-day, 20-day, 50-day, and 100-day moving averages, it remains below its 200-day moving average, suggesting mixed signals...
Read MoreWhy is Evoq Remedies falling/rising?
2025-09-23 23:43:11As of 23-Sep, Evoq Remedies Ltd's stock price is currently at 4.17, reflecting a decrease of 0.1, or 2.34%. The stock has recently experienced a trend reversal, falling after four consecutive days of gains. Despite this decline, the stock has shown strong short-term performance, with a 20.17% increase over the past week and a 21.57% increase over the past month. However, it has significantly underperformed the sector today by 1.99%. The stock's delivery volume has risen dramatically, indicating increased investor participation, but it remains lower than the 200-day moving averages, suggesting potential volatility. There is no information available regarding positive or negative factors that could further explain the stock's recent movement. Broader market context indicates that while Evoq Remedies has had a strong short-term return, it has underperformed compared to the Sensex, which has seen a slight decl...
Read MoreWhy is Evoq Remedies falling/rising?
2025-09-22 23:33:07As of 22-Sep, Evoq Remedies Ltd's stock price is currently at 4.27, reflecting an increase of 0.38, or 9.77%. The stock has been on an upward trend, gaining for the last two days and achieving a total return of 19.27% during this period. Additionally, it has outperformed its sector by 10.85% today. In terms of returns compared to benchmarks, the stock has shown a significant increase of 17.96% over the past week and 24.49% over the past month, despite a year-to-date decline of 45.26%. There is no information available regarding positive or negative factors that could impact the stock's recent movement. Broader Market Context: The Sensex, a key benchmark, has only increased by 0.46% over the past week and 1.05% over the past month, indicating that Evoq Remedies Ltd's short-term performance is significantly stronger than the broader market. This outperformance suggests that investor sentiment towards Evoq Re...
Read MoreDisclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
24-Oct-2025 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Bhumishth Narendrabhai Patel
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
23-Oct-2025 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Bhumishth Narendrabhai Patel
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
23-Oct-2025 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Payal Patel
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






